![Neil Josephson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil Josephson
Hoofd Techniek/Wetenschap/O&O bij
IAMBIC THERAPEUTICS, INC.
Vermogen: 1 M $ op 30-09-2026
Profiel
Dr. Neil Josephson, MD, is a Chief Medical Officer at Iambic Therapeutics, Inc. and an Associate Professor-Medicine at Bloodworks Northwest.
Dr. Josephson was previously employed as a Chief Medical Officer by Zymeworks BC, Inc., a Chief Medical Officer by Zymeworks, Inc., and a Vice President-Clinical Development by Seattle Genetics, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from Columbia University Irving Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-10-2026 | 71.459 ( 0,15% ) | 1 M $ | 30-09-2026 |
Actieve functies van Neil Josephson
| Bedrijven | Functie | Begin |
|---|---|---|
| IAMBIC THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2024 |
Bloodworks Northwest
 Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Corporate Officer/Principal | - |
Eerdere bekende functies van Neil Josephson
| Bedrijven | Functie | Einde |
|---|---|---|
| ZYMEWORKS INC. | Hoofd Techniek/Wetenschap/O&O | 03-01-2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| SEAGEN INC. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Neil Josephson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
59
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bloodworks Northwest
Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Health Services |
Columbia University Medical Center
 Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
 Entos, Inc. BiotechnologyHealth Technology Operates as a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
